Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Study: Middle Age Memory Failures Can Predict Alzheimer’s 18 Years Before Diagnosis

Written by: | andrew.humphreys@medadnews.com | Dated: Sunday, June 28th, 2015

Results from an extensive new study suggest that early symptoms of Alzheimer’s disease appear up to 18 years before the disease is officially diagnosed.

Researchers publishing in the journal Neurology gave 2,125 people, average age 73, a test of memory and thinking skills every three years for 18 years. All of the participants were either European-American or African-American and none had been diagnosed with Alzheimer’s when the study began.

During the course of the study, 23 percent of the African-American and 17 percent of European-American participants developed Alzheimer’s. Those who scored lowest on the memory and thinking tests during the first year of the study were 10 times more likely to develop the disease.

“The changes in thinking and memory that precede obvious symptoms of Alzheimer’s disease begin decades before,” said study author Kumar B. Rajan, PhD, with Rush University Medical Center in Chicago. “While we cannot currently detect such changes in individuals at risk, we were able to observe them among a group of individuals who eventually developed dementia due to Alzheimer’s.”

The most telling period of the study was for memory and thinking tests completed between 13 and 18 years before the research ended. Every single unit of lower performance on the test (a unit being a standard drop below the average score) was associated with an 85 percent greater risk of developing the disease.

According to Rajan, “While that risk is lower than the same one unit lower performance when measured in the year before dementia assessment, the observation that lower test scores 13 to 18 years later indicates how subtle declines in cognitive function affect future risk.”

“Efforts to successfully prevent the disease may well require a better understanding of these processes near middle age,” Rajan said.

The study was published in the journal Neurology.

 

David DiSalvo Contributor

You can find David DiSalvo on Twitter @neuronarrative and at his website daviddisalvo.org.

Pharma & Healthcare

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom